DexCom
DXCM
#895
Rank
S$33.15 B
Marketcap
S$84.55
Share price
0.62%
Change (1 day)
-22.33%
Change (1 year)

Revenue for DexCom (DXCM)

Revenue in 2025 (TTM): S$5.93 Billion

According to DexCom's latest financial reports the company's current revenue (TTM ) is S$5.85 Billion. In 2024 the company made a revenue of S$5.48 Billion an increase over the revenue in the year 2023 that were of S$4.78 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DexCom from 2006 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) S$5.93 B8.28%
2024 S$5.48 B14.59%
2023 S$4.78 B22.64%
2022 S$3.90 B17.85%
2021 S$3.31 B29.87%
2020 S$2.54 B28.09%
2019 S$1.98 B41.2%
2018 S$1.40 B46.65%
2017 S$0.96 B15.82%
2016 S$0.82 B45.92%
2015 S$0.56 B66.03%
2014 S$0.34 B68.95%
2013 S$0.20 B65.99%
2012 S$0.12 B23.65%
2011 S$98.76 M57.67%
2010 S$62.64 M50.27%
2009 S$41.68 M196.32%
2008 S$14.06 M111.29%
2007 S$6.65 M100.13%
2006 S$3.32 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Edwards Lifesciences
EW
S$7.62 B 30.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$27.71 B 373.57%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
S$3.91 B-33.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
S$1.30 B-77.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$44.31 B 657.32%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Abbott Laboratories
ABT
S$56.80 B 870.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$119.39 B 1,940.55%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
S$3.51 B-39.89%๐Ÿ‡บ๐Ÿ‡ธ USA